EA201270359A1 - Терапевтическое средство от расстройств настроения - Google Patents
Терапевтическое средство от расстройств настроенияInfo
- Publication number
- EA201270359A1 EA201270359A1 EA201270359A EA201270359A EA201270359A1 EA 201270359 A1 EA201270359 A1 EA 201270359A1 EA 201270359 A EA201270359 A EA 201270359A EA 201270359 A EA201270359 A EA 201270359A EA 201270359 A1 EA201270359 A1 EA 201270359A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- mood disorders
- therapeutic means
- therapeutic
- pharmaceutically acceptable
- general formula
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/052—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Описывается терапевтическое и/или профилактическое средство от расстройств настроения, которое содержит в качестве активного ингредиента производное тиазола, представленное общей формулой (I) (где Rпредставляет собой арильную группу или аналогичные и Rпредставляет пиридильную группу или аналогичные), или его фармацевтически приемлемую соль.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009202893 | 2009-09-02 | ||
PCT/JP2010/064988 WO2011027805A1 (ja) | 2009-09-02 | 2010-09-02 | 気分障害治療剤 |
Publications (2)
Publication Number | Publication Date |
---|---|
EA201270359A1 true EA201270359A1 (ru) | 2012-09-28 |
EA030333B1 EA030333B1 (ru) | 2018-07-31 |
Family
ID=43649339
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201270359A EA030333B1 (ru) | 2009-09-02 | 2010-09-02 | Способ лечения и/или предотвращения расстройств настроения |
Country Status (31)
Country | Link |
---|---|
US (1) | US9249135B2 (ru) |
EP (1) | EP2474543B1 (ru) |
JP (1) | JP5663484B2 (ru) |
KR (1) | KR101762981B1 (ru) |
CN (1) | CN102482272A (ru) |
AU (1) | AU2010290423B2 (ru) |
BR (1) | BR112012004851B8 (ru) |
CA (1) | CA2772920C (ru) |
CL (1) | CL2012000534A1 (ru) |
CY (1) | CY1119118T1 (ru) |
DK (1) | DK2474543T3 (ru) |
DO (1) | DOP2012000058A (ru) |
EA (1) | EA030333B1 (ru) |
ES (1) | ES2633538T3 (ru) |
GE (1) | GEP20156224B (ru) |
HR (1) | HRP20171137T1 (ru) |
HU (1) | HUE033690T2 (ru) |
IL (1) | IL218321A (ru) |
LT (1) | LT2474543T (ru) |
MA (1) | MA33618B1 (ru) |
ME (1) | ME02804B (ru) |
MX (1) | MX2012002528A (ru) |
NZ (1) | NZ598750A (ru) |
PL (1) | PL2474543T3 (ru) |
PT (1) | PT2474543T (ru) |
RS (1) | RS56345B1 (ru) |
SI (1) | SI2474543T1 (ru) |
TN (1) | TN2012000092A1 (ru) |
UA (1) | UA110097C2 (ru) |
WO (1) | WO2011027805A1 (ru) |
ZA (1) | ZA201202346B (ru) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK3002283T3 (en) * | 2003-12-26 | 2017-07-10 | Kyowa Hakko Kirin Co Ltd | THIAZOLE DERIVATIVES. |
UA113383C2 (xx) * | 2009-09-02 | 2017-01-25 | Терапевтичний агент для лікування тривожних розладів | |
MA41090A (fr) * | 2014-12-03 | 2017-10-10 | H Lundbeck As | Antagoniste de a2a faiblement dosé pour le traitement du tdah et de la maladie de parkinson |
JOP20200093A1 (ar) * | 2015-01-09 | 2017-06-16 | Kyowa Kirin Co Ltd | طريقة لإنتاج مشتق ثيازول |
JO3544B1 (ar) * | 2015-03-19 | 2020-07-05 | Kyowa Kirin Co Ltd | عامل علاجي للاختلال الوظيفي في الفص الجبهي |
TW201803869A (zh) | 2016-04-27 | 2018-02-01 | 健生藥品公司 | 作為RORγT調節劑之6-胺基吡啶-3-基噻唑 |
WO2019244001A1 (en) | 2018-06-18 | 2019-12-26 | Janssen Pharmaceutica Nv | 6-aminopyridin-3-yl pyrazoles as modulators of roryt |
CA3103929A1 (en) | 2018-06-18 | 2019-12-26 | Janssen Pharmaceutica Nv | Phenyl substituted pyrazoles as modulators of roryt |
CA3103932A1 (en) | 2018-06-18 | 2019-12-26 | Janssen Pharmaceutica Nv | Pyridinyl pyrazoles as modulators of roryt |
ES2929140T3 (es) | 2018-06-18 | 2022-11-25 | Janssen Pharmaceutica Nv | Imidazoles sustituidos con fenilo y piridinilo como moduladores de RORgammat |
WO2023201267A1 (en) | 2022-04-13 | 2023-10-19 | Gilead Sciences, Inc. | Combination therapy for treating trop-2 expressing cancers |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK0628311T3 (da) | 1992-07-08 | 2002-07-22 | Kyowa Hakko Kogyo Kk | Xanthinderivater som antidepressive midler |
EP1666041A3 (en) | 1997-09-05 | 2008-04-02 | Kyowa Hakko Kogyo Co., Ltd. | Xanthine derivatives for treating neurodegenerative disorders |
CA2459304A1 (en) * | 2001-09-13 | 2003-03-20 | Schering Corporation | Combination of an adenosine a2a receptor antagonist and an antidepressant or anxiolytic |
US6620811B2 (en) | 2001-11-19 | 2003-09-16 | Hoffmann-La Roche Inc. | Isonicotin- and nicotinamide derivatives of benzothiazoles |
JP4778894B2 (ja) | 2003-06-10 | 2011-09-21 | 協和発酵キリン株式会社 | 不安障害の治療方法 |
DK3002283T3 (en) | 2003-12-26 | 2017-07-10 | Kyowa Hakko Kirin Co Ltd | THIAZOLE DERIVATIVES. |
WO2005095357A2 (en) | 2004-03-30 | 2005-10-13 | Taisho Pharmaceutical Co., Ltd. | Pyrimidine derivatives and methods of treatment related to the use thereof |
JPWO2006137527A1 (ja) * | 2005-06-23 | 2009-01-22 | 協和発酵キリン株式会社 | チアゾール誘導体 |
DK1921077T3 (en) | 2005-08-02 | 2017-10-23 | Kyowa Hakko Kirin Co Ltd | Means for treating and / or preventing sleep disorders |
-
2010
- 2010-02-09 UA UAA201203928A patent/UA110097C2/uk unknown
- 2010-09-02 EA EA201270359A patent/EA030333B1/ru unknown
- 2010-09-02 BR BR112012004851A patent/BR112012004851B8/pt not_active IP Right Cessation
- 2010-09-02 HU HUE10813753A patent/HUE033690T2/hu unknown
- 2010-09-02 AU AU2010290423A patent/AU2010290423B2/en not_active Ceased
- 2010-09-02 WO PCT/JP2010/064988 patent/WO2011027805A1/ja active Application Filing
- 2010-09-02 SI SI201031510T patent/SI2474543T1/sl unknown
- 2010-09-02 ES ES10813753.0T patent/ES2633538T3/es active Active
- 2010-09-02 RS RS20170748A patent/RS56345B1/sr unknown
- 2010-09-02 PT PT108137530T patent/PT2474543T/pt unknown
- 2010-09-02 EP EP10813753.0A patent/EP2474543B1/en active Active
- 2010-09-02 GE GEAP201012647A patent/GEP20156224B/en unknown
- 2010-09-02 CN CN2010800392296A patent/CN102482272A/zh active Pending
- 2010-09-02 MX MX2012002528A patent/MX2012002528A/es active IP Right Grant
- 2010-09-02 US US13/393,035 patent/US9249135B2/en not_active Expired - Fee Related
- 2010-09-02 ME MEP-2017-168A patent/ME02804B/me unknown
- 2010-09-02 LT LTEP10813753.0T patent/LT2474543T/lt unknown
- 2010-09-02 CA CA2772920A patent/CA2772920C/en not_active Expired - Fee Related
- 2010-09-02 PL PL10813753T patent/PL2474543T3/pl unknown
- 2010-09-02 JP JP2011529926A patent/JP5663484B2/ja active Active
- 2010-09-02 DK DK10813753.0T patent/DK2474543T3/en active
- 2010-09-02 NZ NZ598750A patent/NZ598750A/en not_active IP Right Cessation
- 2010-09-02 KR KR1020127008307A patent/KR101762981B1/ko active IP Right Grant
-
2012
- 2012-02-26 IL IL218321A patent/IL218321A/en active IP Right Grant
- 2012-02-27 TN TNP2012000092A patent/TN2012000092A1/en unknown
- 2012-02-29 CL CL2012000534A patent/CL2012000534A1/es unknown
- 2012-03-01 DO DO2012000058A patent/DOP2012000058A/es unknown
- 2012-03-30 MA MA34733A patent/MA33618B1/fr unknown
- 2012-03-30 ZA ZA2012/02346A patent/ZA201202346B/en unknown
-
2017
- 2017-07-21 HR HRP20171137TT patent/HRP20171137T1/hr unknown
- 2017-07-26 CY CY20171100798T patent/CY1119118T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201270359A1 (ru) | Терапевтическое средство от расстройств настроения | |
EA201390908A1 (ru) | Производные бицикло[3.2.1]октиламида и их применение | |
WO2011058474A8 (en) | N1-pyrazolospiroketone acetyl-coa carboxylase inhibitors | |
EA201170872A1 (ru) | Ингибиторы протеинкиназы | |
TW200728307A (en) | Novel spirochromanone derivatives | |
AU2009258496A8 (en) | Sulfur-containing heterocyclic derivative having beta-secretase-inhibiting activity | |
EA201390885A1 (ru) | Азаиндолы в качестве противовирусных агентов против респираторного синцитиального вируса | |
RS53617B1 (en) | NEW UNITS USEFUL FOR TREATMENT OF DEGENERATIVE AND INFLAMMATORY DISEASES | |
CY1112429T1 (el) | Υποκατεστημενα παραγωγα σουλφοναμιδιου | |
EA201391486A1 (ru) | Способы и композиции для лечения болезни паркинсона | |
RS53613B1 (en) | COMPOUNDS, COMPOSITIONS, AND PROCEDURES FOR TREATMENT OF BETA-AMYLOID DISEASES AND SYNUCLEINOPATHY | |
ATE449776T1 (de) | Pyrroloä2,3-cüpyridinderivate | |
NZ596362A (en) | Therapeutic agent for motor disorders | |
RS52108B (en) | 3-SUBSTITUTED [1,2,3] -BENZOTRIAZINONE UNIT TO INCREASE GLUTAMATERGIC SYNAPTIC ANSWERS | |
PH12016502246B1 (en) | Carboxamide derivatives | |
MX341341B (es) | Derivados de benzamida y su uso como inhibidores de proteina de choque termico 90 kda (hsp90). | |
TN2016000491A1 (en) | Carboxamide derivatives. | |
WO2011159124A3 (ko) | Interleukin-6 억제 작용을 갖는 신규한 벤즈옥사졸 유도체, 이의 제조 방법 및 이를 포함하는 약학적 조성물 | |
CY1119483T1 (el) | Θεραπευτικος παραγων για τις αγχωδεις διαταραχες | |
EA201070367A1 (ru) | Производное 6-пиримидинилпиримид-4-она | |
MX2012012410A (es) | Agente terapeutico y agente preventivo para enfermedad de alzheimer. | |
WO2013062332A3 (ko) | 시링가레시놀을 포함하는 혈관 노화 억제용 조성물 | |
WO2011102660A3 (en) | A novel 5-membered heterocycle derivatives and manufacturing process thereof | |
WO2012125663A3 (en) | Cyclohexane substituted amino cyclopentane derivatives as useful ccr2 antagonists | |
EA200901085A1 (ru) | Производные циклогексиламида арилкарбоновой кислоты |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
TC4A | Change in name of a patent proprietor in a eurasian patent |